Worth Venture Partners, LLC Ani Pharmaceuticals Inc Transaction History

Worth Venture Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$37.29 - $53.83 $71,373 - $103,030	1,914 Added 2.24%	87,472 $4.71 Million
Q1 2023 May 15, 2023	SELL	$37.61 - $45.72 $92,482 - $112,425	-2,459 Reduced 2.79%	85,558 $3.4 Million
Q4 2022 Feb 14, 2023	BUY	$31.9 - $41.95 $311,535 - $409,683	9,766 Added 12.48%	88,017 $3.54 Million
Q3 2022 Nov 14, 2022	BUY	$29.83 - $38.01 $519,638 - $662,134	17,420 Added 28.64%	78,251 $2.52 Million
Q2 2022 Aug 15, 2022	BUY	$23.09 - $33.46 $1.4 Million - $2.04 Million	60,831 New	60,831 $1.93 Million

210

18.2M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.01B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.